MENU
GLUE
AS OF
Dec 24 closing price
Price
$17.64
Change
+$1.16 (+7.04%)
Capitalization
1.15B
77 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
GLUE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Monte Rosa Therapeutics (GLUE) Ownership - Who owns Monte Rosa Therapeutics?

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.15B
P/E Ratio
55.13
Total Cash
391.26M
Projected Growth
N/A
Total Debt
40.17M
Revenue
181.54M
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash/Share
6.01
Total Debt/Equity
N/A
Revenue/Share
2.19 USD as % of share price

Fundamentals

GLUE
Capitalization
1.15B
P/E Ratio
55.13
Risk (Beta)
2.14
Dividend Yield
N/A
Total Cash
391M
Total Cash/Share
6.01
Total Debt
40.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.19%
Revenue
182M
ROE
N/A
Book Value
246M
P/B Ratio
4.67
Cash Flow
N/A
Earnings
0.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
6.54
Current Revenue Per Employee
86857.14
Dividends Per Share - Security
N/A
EBITDA
16.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
5.41
Shares Held By Institutions
671M
Shares Outstanding - Current
65.1M
Total Liabilities
214M
Total Volume MTD
N/A
Value
-1
Gain YTD
154.179
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GLUE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GLUE showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for GLUE
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 949-2643
Employees
133
Web
https://www.monterosatx.com